Jesús Martin-Garcia
Chief Executive Officer at GENEURO SA
Jesús Martin-Garcia active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENEURO SA | Chief Executive Officer | 01/01/2006 | - |
| Chairman | 06/02/2006 | - | |
| Founder | 01/01/2006 | - | |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Director/Board Member | - | - |
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Corporate Officer/Principal | - | - |
| Association Des Industries Genevoises Des Sciences De La Vie | Chairman | - | - |
| DePGen SA | Director/Board Member | - | - |
| Harvard Business School Health Industry Alumni Association | Director/Board Member | - | - |
GeNeuro SA
 GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Chairman | 26/05/2011 | - |
| Union des Associations Patronales Genevoises | Director/Board Member | - | - |
Career history of Jesús Martin-Garcia
Former positions of Jesús Martin-Garcia
| Companies | Position | Start | End |
|---|---|---|---|
| GENKYOTEX SA. | Director/Board Member | 28/02/2017 | 03/11/2020 |
| ░░░░░ ░░░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░░░░░░ ░ ░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░░░░░ ░ ░░░░ ░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░ | ░░░░░░░░ | - | - |
| ░░░░░░ ░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Jesús Martin-Garcia
| Harvard Business School | Masters Business Admin |
| University of Geneva | Graduate Degree |
Statistics
International
| Switzerland | 14 |
| United States | 5 |
| France | 4 |
Operational
| Director/Board Member | 7 |
| Corporate Officer/Principal | 6 |
| Chairman | 5 |
Sectoral
| Health Technology | 6 |
| Commercial Services | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Private companies | 17 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Commercial Services |
LeShop SA
 LeShop SA Food RetailRetail Trade Part of Migros Group, LeShop SA is an online grocery service. The company is based in Chavannes-de-Bogis, Switzerland. The Swiss company was founded by Jesús Martin-Garcia. LeShop was acquired by Migros-Genossenschafts-Bund from ShoppingNet Holding SA on April 05, 2006. | Retail Trade |
GeNeuro SA
GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Health Technology |
ArisGen SA
 ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Health Technology |
| Mckinsey & Co., Inc. (Switzerland) | |
Eclosion Foundation
 Eclosion Foundation Investment Trusts/Mutual FundsMiscellaneous Eclosion Foundation offers researchers managerial and scientific support for their projects, from finance to validation resources. The firm also provides premises, laboratories, and services adapted to the needs of their clients. It focuses on biotechnology and biomedical engineering sectors. The company was founded by Jesús Martin-Garcia and Benoit Dubois and is headquartered in Plan-les-Ouates, Switzerland. | Miscellaneous |
| Harvard Business School Health Industry Alumni Association | |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Finance |
| Eclosion2 & Cie Scpc | |
| DePGen SA | |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France. | Health Technology |
| Melcure SA | |
| Association Des Industries Genevoises Des Sciences De La Vie | |
Value Management Group LLC
 Value Management Group LLC Miscellaneous Commercial ServicesCommercial Services Value Management Group LLC engages in the provision of healthcare valuation and advisory services. It offers physician compensation valuation and value-based arrangements, real estate appraisal, capital asset appraisal, financial due diligence, litigation and dispute resolution, compensation plan design and consulting, and other healthcare transaction advisory. The company was founded by Greg Koonsman in 1995 and is headquartered in Dallas, TX. | Commercial Services |
| Union des Associations Patronales Genevoises |
- Stock Market
- Insiders
- Jesús Martin-Garcia
- Experience
